| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5616285 | The Journal of Thoracic and Cardiovascular Surgery | 2017 | 8 Pages |
Abstract
Positive EGFR mutation status is a favorable prognostic factor in patients with surgically resected lung adenocarcinomas; however, EGFR mutation subtype (exon 21 L858R mutation or exon 19 deletion) exhibits no prognostic impact.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Kazuya MD, Shiaki MD, Takeshi MD, Kenji MD,